Tag: colorectal

In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer—a disease that kills more than 50,000 people each year in the United States. The team identified a novel mechanism by which colorectal cancer cells evade an anti-tumor immune response, which helped them

Regenstrief Institute and Indiana University School of Medicine research scientists have developed and tested one of the first U.S.-based models to predict personal risk for advanced precancerous polyps and colon cancer in average risk individuals. Colorectal cancer is the third most common cancer and second most lethal cancer in the U.S. Especially during the COVID-19

Colorectal cancer kills more than 50,000 people a year in the United States alone, but scientists have struggled to find the exact mechanisms that trigger the growth of tumors in the intestine. Cancer researchers have zeroed in on a tightly sequestered group of stem cells within the intestine as suspects in the development of colon

Patients with polyps have a higher risk of colorectal cancer, and those with sessile serrated polyps, tubulovillous adenomas, and villous adenomas had a higher colorectal cancer mortality. Colorectal cancer is the third most common cancer and the second leading cause of cancer death worldwide. Endoscopic screening reduces colorectal cancer and mortality by detection and removal

The burden of colorectal cancer is swiftly shifting to younger individuals as incidence increases in young adults and declines in older age groups, according to the latest edition of Colorectal Cancer Statistics 2020, a publication of the American Cancer Society. A sign of the shift: the median age of diagnosis has dropped from age 72

A new technique could dramatically reduce the number of colorectal cancer patients who unnecessarily undergo major surgery to remove tumors, instead of a minimally invasive procedure. Biomedical scientist Xin Wang of City University of Hong Kong and colleagues have used machine learning to identify a gene expression pattern, or signature, associated with colorectal cancer spreading,

Recent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer Society guidelines recommending screening in that age group, according to a new study. The increase in was unique to the 45 to 49 year-old age group according to the study, which

Many patients diagnosed with colorectal cancer before age 50 were initially misdiagnosed, which may lead to diagnosis at an advanced stage of the disease, according to survey results presented during a media preview of the AACR Annual Meeting 2019, to be held March 29-April 3, in Atlanta. “Despite declining incidence in older adults, there has

WEDNESDAY, Dec. 5, 2018 — Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the British Journal of Cancer. Yanan Ma, from China Medical University in Shenyang, and colleagues followed 87,523 women from the

A program that provided individually tailored lifestyle recommendations for patients undergoing screening for colorectal cancer helped encourage healthy behavior, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. “It is well known that a healthy lifestyle decreases the risk of colorectal cancer,” said the study’s

Kaiser Permanente members in Northern California are 52 percent less likely to die from colorectal cancer since the health care system launched a comprehensive, organized screening program, according to a new study in the specialty’s top journal, Gastroenterology. “Since we launched our screening program we have seen a remarkable decline in the number of cases

The American Cancer Society released new colorectal cancer screening guidelines today, suggesting that testing begin at age 45 rather than 50 for people at average risk of the disease. The change comes just over a year after ACS researchers reported a dramatic uptick in colorectal cancer cases in younger adults: Compared to people born in

A national retrospective study led by researchers at The University of Texas MD Anderson Cancer Center found no association between intensity of post-treatment surveillance and detection of recurrence or overall survival (OS) in patients with stage I, II or III colorectal cancer (CRC). Published in the Journal of the American Medical Association, the study is